Trials / Completed
CompletedNCT00184522
On Demand Treatment of Reflux Disease
Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 82 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A comparison of the effect of on demand treatment with a pectin-containing natural product (Aflurax) with that esomeprazole (Nexium)
Detailed description
A randomized, controlled, open trial comparing the symptomatic effect of a pectin-containing product (Aflurax) with that of esomeprazole (Nexium 20 mg) given on-demand for 6 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aflurax | |
| DRUG | esomeprazole |
Timeline
- Start date
- 2002-08-01
- Primary completion
- 2004-11-01
- Completion
- 2004-12-01
- First posted
- 2005-09-16
- Last updated
- 2011-08-09
Locations
9 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT00184522. Inclusion in this directory is not an endorsement.